Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ: CRBP · Real-Time Price · USD
6.45
-0.20 (-3.01%)
At close: May 9, 2025, 4:00 PM
6.30
-0.15 (-2.33%)
After-hours: May 9, 2025, 6:49 PM EDT
CRBP Stock Forecast
CRBP's stock price has decreased by -84.78% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 9 analysts with 12-month price forecasts for CRBP stock have an average target of 53.56, with a low estimate of 35 and a high estimate of 75. The average target predicts an increase of 730.39% from the current stock price of 6.45.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CRBP stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 4 | 4 | 4 |
Buy | 5 | 5 | 6 | 6 | 6 | 6 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 8 | 8 | 9 | 10 | 10 | 10 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
RBC Capital | RBC Capital | Buy Maintains $65 → $58 | Buy | Maintains | $65 → $58 | +799.22% | May 7, 2025 |
Oppenheimer | Oppenheimer | Buy Maintains $60 → $56 | Buy | Maintains | $60 → $56 | +768.22% | May 7, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $50 → $40 | Strong Buy | Maintains | $50 → $40 | +520.16% | May 7, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $75 → $50 | Strong Buy | Reiterates | $75 → $50 | +675.19% | Mar 12, 2025 |
Jefferies | Jefferies | Strong Buy Maintains $70 → $53 | Strong Buy | Maintains | $70 → $53 | +721.71% | Mar 11, 2025 |
Financial Forecast
Revenue This Year
1.70M
Revenue Next Year
4.25M
from 1.70M
Increased by 150.00%
EPS This Year
-5.28
from -3.68
EPS Next Year
-5.04
from -5.28
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 10.5M | 26.3M | 26.3M | ||
Avg | 1.7M | 4.3M | 4.3M | ||
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | 1,444.1% | 517.6% | ||
Avg | - | 150.0% | - | ||
Low | - | - | - |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -3.02 | -3.30 | -2.93 | ||
Avg | -5.28 | -5.04 | -6.16 | ||
Low | -12.31 | -6.18 | -8.17 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.